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Items for this week’s EPI Update include: 
  
• Merck recalls Hib Vaccine  
•     “Ethical Framework for Use in a Pandemic” now available  
• Flu activity still sporadic; all three strains circulating  
• Norovirus  
• Meeting announcements and training opportunities  
  
Merck recalls Hib Vaccine 
  
Merck and Co., Inc. (“Merck”) has initiated a voluntary, class-2 recall of two of 
their Haemophilus influenzae type B (Hib) vaccines. The products are 
PedvaxHIB and COMVAX (a combination Hib + Hepatitis B vaccine).  
  
• There is no need to revaccinate children who have received the recalled 
vaccine. The vaccine’s efficacy in providing protection against this disease 
is unchanged.  
  
• No adverse reaction to the recalled vaccine has been reported in Iowa and 
the Centers for Disease Control and Prevention (CDC) has reported no 
adverse reactions in the U.S. If an adverse reaction were to occur, it would 
be a local infection at the vaccine injection site and would occur within one 
week of vaccination.  
  
• Vaccine providers in Iowa are being notified. Providers known to have 
received the recalled vaccine are being personally contacted by IDPH.  
  
About 1 million doses of the vaccine are being voluntarily recalled as a part of 
quality assurance measures. The risk of a reaction to the recalled vaccine is 
extremely low, but providers should immediately discontinue use of any of the 
affected lots and follow Merck’s instructions for returning recalled vaccine.  
  
For more information about the recalls, visit: 
  
www.merck.com/newsroom/press_releases/product/2007_1212.html; or 
www.cdc.gov/vaccines/recs/recalls/hib-recall-faqs-12-12-07.htm. 
  
“Ethical Framework for Use in a Pandemic” now available  
  
A new document is available on the IDPH Web site to guide local public health 
officials in preparing for and responding to a pandemic influenza outbreak. 
Developed by the Iowa Pandemic Influenza Ethics Committee, this valuable 
document provides a framework for decision making and examples on how to 
make ethical decisions in public health disaster situations.  
  
Statewide education and distribution of this document will begin soon.  In the 
meantime, please visit www.idph.state.ia.us/pandemic and look under “General 
Information.”  
  
Flu activity still sporadic; all three strains circulating 
Influenza activity is sporadic throughout Iowa. However, the University Hygienic 
Laboratory (UHL) has identified all three strains from specimens submitted for 
this season (AH1, AH3, and B). All health care providers are encouraged to 
submit specimens to UHL for type and strain determination. Submitting 
specimens allows UHL and CDC to determine which strains are predominant in 
Iowa and whether those strains match the vaccine.  
  
For more information on influenza specimen submission, visit 
www.uhl.uiowa.edu/kitsquotesforms or call the lab at 319-335-4500.  
  
For more information about the weekly influenza surveillance reports, visit 
www.idph.state.ia.us/adper/iisn.asp. 
  
Norovirus 
  
In the past month, several norovirus outbreaks have occurred in the state. 
Norovirus specimens from patients should be submitted for laboratory testing to 
UHL. It is recommended to collect specimens from three to five ill persons 
associated with an outbreak for accurate laboratory confirmation. UHL has the 
ability to test for noroviruses by (real-time) RT-PCR, which detects the norovirus 
RNA in stool specimens.  
  
Detection of norovirus in a stool is optimal if obtained within 48 to 72 hours after 
onset of symptoms. The virus can often be detected as long as five days after 
symptom onset and up to two weeks after recovery. Either fresh stool stored and 
shipped on ice packs or stool in enteric transport medium (ETM) are good 
specimens. ETM allows for Norovirus testing in addition to bacteriologic testing 
and can be shipped at ambient temperature for arrival at UHL no later than three 
days post collection. Vomitus will be considered under special circumstances, but 
is not an optimal specimen due to the low pH. 
 
The Epi Manual contains several resources, including a norovirus environmental 
cleaning fact sheet and outbreak recommendations for schools, workplaces, child 
care centers, long-term care facilities and hospitals. These materials can be 
found in the Epi Manual Chapter “Information on Other Diseases” at 
http://www.idph.state.ia.us/idph_universalhelp/main.aspx?system=IdphEpiManua
l  . 
Test request forms for RT-PCR testing of Norovirus are available at 
www.uhl.uiowa.edu/kitsquotesforms/vdvbpcrrequestform.pdf. 
 
For more information, or to request ETM, please call UHL at 
319-335-4500 and ask to speak to someone in the Molecular Biology or 
Bacteriology Departments. 
  
Meeting announcements and training opportunities 
None 
  
  
Have a healthy and happy week, and walk carefully on all this ice! 
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